HCA Healthcare's stock has performed well, rising 26% in the past year, and with more confidence in the outlook, I am returning to a "buy" rating. The company's Q1 results showed strong revenue growth and rising demand, leading to a healthy margin environment. HCA is benefiting from a better payer mix, cost control measures, and accelerating hospital pricing, which is exceeding expectations and should persist into 2025.
Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Focus List.
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investing style. Here's why you should take advantage.
With healthcare spending projected to grow 5.4% annually through 2031, healthcare stocks remain highly compelling investments in the current market. As one of the few sectors with near-guaranteed growth trajectories thanks to constant consumer demand, healthcare stocks to buy right now present investors with stability and upside.
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.